Covaxin
BHU study on Covaxin side effects poorly designed, erroneously acknowledgesICMR: Dr Bahl
Over 30% Covaxin takers suffered from health issues after 1 year, claims BHU study
No link between Covid vaccines used in India and heart attack risk: Study
ICMR study indicates Covaxin booster dose safe, necessary for persistent immunity
Booster dose of Covishield offers best immune response: Lancet study
Covishield more efficient than Covaxin against Covid variants: Study
Bharat Biotech's intranasal COVID-19 vaccine to cost Rs 800 for private markets